These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6997726)

  • 1. Mechanism of N-hydroxyacetylarylamine mutagenicity in the Salmonella test system: metabolic activation of N-hydroxyphenacetin by liver and kidney fractions from rat, mouse, hamster, and man.
    Wirth PJ; Dybing E; von Bahr C; Thorgeirsson SS
    Mol Pharmacol; 1980 Jul; 18(1):117-27. PubMed ID: 6997726
    [No Abstract]   [Full Text] [Related]  

  • 2. Species-specific activation of phenacetin into bacterial mutagens by hamster liver enzymes and identification of N-hydroxyphenacetin O-glucuronide as a promutagen in the urine.
    Camus AM; Friesen M; Croisy A; Bartsch H
    Cancer Res; 1982 Aug; 42(8):3201-8. PubMed ID: 7046920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of species differences in N-hydroxyphenacetin mutagenicity: the role of deacetylation by rat and hamster liver microsomes.
    Nohmi T; Yoshikawa K; Ishidate M; Hiratsuka A; Watabe T
    Chem Pharm Bull (Tokyo); 1984 Nov; 32(11):4525-31. PubMed ID: 6398128
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat.
    Schut HA; Wirth PJ; Thorgeirsson SS
    Mol Pharmacol; 1978 Jul; 14(4):682-92. PubMed ID: 683178
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of N-hydroxyphenacetin to mutagenic and nucleic acid-binding metabolites by acyltransfer, deacylation, and sulfate conjugation.
    Vaught JB; McGarvey PB; Lee MS; Garner CD; Wang CY; Linsmaier-Bednar EM; King CM
    Cancer Res; 1981 Sep; 41(9 Pt 1):3424-9. PubMed ID: 7020926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the ability of phenacetin, acetaminophen, and aspirin to induce cytotoxicity, mutation, and morphological transformation in C3H/10T1/2 clone 8 mouse embryo cells.
    Patierno SR; Lehman NL; Henderson BE; Landolph JR
    Cancer Res; 1989 Feb; 49(4):1038-44. PubMed ID: 2912548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR.
    Wirth PJ; Alewood P; Calder I; Thorgeirsson SS
    Carcinogenesis; 1982; 3(2):167-70. PubMed ID: 6896016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells.
    Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS
    Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic activation of p-nitrotoluene and trichloroethylene by rat-liver S9 or mouse-liver S9 fractions in Salmonella typhimurium strains (author's transl)].
    Miyata R; Nohmi T; Yoshikawa K; Ishidate M
    Eisei Shikenjo Hokoku; 1981; 99():60-5. PubMed ID: 7037091
    [No Abstract]   [Full Text] [Related]  

  • 11. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals.
    Zeiger E; Anderson B; Haworth S; Lawlor T; Mortelmans K; Speck W
    Environ Mutagen; 1987; 9 Suppl 9():1-109. PubMed ID: 3552650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of N-hydroxyphenacetin in vitro and in vivo.
    Fischbach T; Lenk W
    Xenobiotica; 1985 Nov; 15(11):915-27. PubMed ID: 4082632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
    Hales BF
    Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species difference in the metabolic activation of phenacetin by rat and hamster liver microsomes.
    Nohmi T; Yoshikawa K; Nakadate M; Ishidate M
    Biochem Biophys Res Commun; 1983 Feb; 110(3):746-52. PubMed ID: 6404262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation by hamster and rat hepatocytes in the Salmonella mutagenicity assay.
    Poiley JA; Raineri R; Andrews AW; Cavanaugh DM; Pienta RJ
    J Natl Cancer Inst; 1980 Dec; 65(6):1293-8. PubMed ID: 7001125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity of the phenacetin metabolites: N-hydroxy-p-phenetidine and nitrosophenetol in S. typhimurium TA100 and derivatives deficient in nitroreductase or O-acetylase: probes for testing intrabacterial metabolic activation.
    McCoy EC; Rosenkranz HS; Bartsch H
    Mutat Res; 1986 Apr; 173(4):245-50. PubMed ID: 3513003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity testing of selected analgesics in Ames Salmonella strains.
    Oldham JW; Preston RF; Paulson JD
    J Appl Toxicol; 1986 Aug; 6(4):237-43. PubMed ID: 3531298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide.
    Kaneda S; Seno T; Takeishi K
    J Natl Cancer Inst; 1981 Sep; 67(3):549-55. PubMed ID: 6944527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.